Introduction: Noninvasive frameless modalities have become increasingly utilized for stereotactic radiosurgery (SRS) for benign and malignant pathologies. There is minimal comparison in the literature of frame-based (FB) and mask-based (MB) SRS. With the dual capabilities of the Elekta Gamma Knife® Icon™, we sought to compare patient perceptions of FB and MB SRS with respect to comfort and pain and to examine effects of lesion type on the patient experience of SRS. Methods: Over a 1-year period, patients who underwent single fraction, fractionated or hypofractionated FB or MB Gamma Knife SRS at our institution were given an 8-question survey about their experience with the procedure immediately after treatment was completed. Descriptive statistics were applied. Results: A total of 117 patients completed the survey with 65 FB and 52 MB SRS treatments. Mean pain for FB SRS (5.64 ± 2.55) was significantly greater than mean pain for MB SRS (0.92 ± 2.24; t114 = 10.46, p < 0.001). Patient comfort during the procedure was also higher for those having MB SRS (p < 0.001). Mixed results were obtained when investigating if benign versus malignant diagnosis affected patient experience of SRS. For the purposes of this study, malignant diagnoses were almost entirely metastatic lesions. Diagnosis played no role on pain levels when all patients were analyzed together. The treatment technique had no effect on patient comfort in patients with benign diagnoses, while patients with malignant diagnoses treated with MB SRS were more likely to be comfortable (p < 0.001). Among patient’s receiving FB treatments, diagnosis played no role on patient comfort. When only MB treatments were analyzed, patients were more likely to be comfortable if they had a malignant lesion (p < 0.01). Conclusions: Patients treated with MB SRS experience the procedure as more comfortable and less painful compared to those treated using a FB modality. Overall, this difference was not affected by a benign versus a malignant diagnosis and the treatment type is more indicative of the patient experience during SRS. A more homogenous sample between modalities and diagnoses and further follow-up with the patient’s input on their experience would be beneficial.

1.
Kushnirsky
M
,
Patil
V
,
Schulder
M
.
The history of stereotactic radiosurgery
. In:
Chin
LS
,
Regine
WF
, editors.
Principles and practice of stereotactic radiosurgery
.
New York, NY
:
Springer
;
2015
. p.
3
10
.
2.
Li
G
,
Ballangrud
A
,
Kuo
LC
,
Kang
H
,
Kirov
A
,
Lovelock
M
, et al.
Motion monitoring for cranial frameless stereotactic radiosurgery using video-based three-dimensional optical surface imaging
.
Med Phys
.
2011
;
38
(
7
):
3981
94
. .
3.
Carminucci
A
,
Nie
K
,
Weiner
J
,
Hargreaves
E
,
Danish
SF
.
Assessment of motion error for frame-based and noninvasive mask-based fixation using the Leksell gamma knife icon radiosurgery system
.
J Neurosurg
.
2018
;
129
(
Suppl 1
):
133
9
. .
4.
Belcher
AH
,
Liu
X
,
Chmura
S
,
Yenice
K
,
Wiersma
RD
.
Towards frameless maskless SRS through real-time 6DoF robotic motion compensation
.
Phys Med Biol
.
2017
;
62
(
23
):
9054
66
. .
5.
Babic
S
,
Lee
Y
,
Ruschin
M
,
Lochray
F
,
Lightstone
A
,
Atenafu
E
, et al.
To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy
.
J Appl Clin Med Phys
.
2018
;
19
(
2
):
111
20
. .
6.
Chung
HT
,
Kim
JH
,
Kim
JW
,
Paek
SH
,
Kim
DG
,
Chun
KJ
, et al.
Assessment of image co-registration accuracy for frameless gamma knife surgery
.
PLoS One
.
2018
;
13
(
3
):
e0193809
. .
7.
Lunsford
LD
,
Niranjan
A
,
Fallon
K
,
Kim
JO
.
Frame versus frameless Leksell stereotactic radiosurgery
.
Prog Neurol Surg
.
2019
;
34
:
19
27
. .
8.
Grimm
MA
,
Köppen
U
,
Stieler
F
,
Welzel
G
,
Ruder
AM
,
Polednik
M
, et al.
Prospective assessment of mask versus frame fixation during gamma knife treatment for brain metastases
.
Radiother Oncol
.
2020
;
147
:
195
9
. .
9.
Bennion
NR
,
Malouff
T
,
Verma
V
,
Denniston
K
,
Bhirud
A
,
Zhen
W
, et al.
A comparison of clinical and radiologic outcomes between frame-based and frameless stereotactic radiosurgery for brain metastases
.
Pract Radiat Oncol
.
2016
;
6
(
6
):
e283
90
. .
10.
Lunsford
LD
,
Flickinger
J
,
Lindner
G
,
Maitz
A
.
Stereotactic radiosurgery of the brain using the first United States 201 cobalt-60 source gamma knife
.
Neurosurgery
.
1989
;
24
(
2
):
151
9
. .
11.
Vulpe
H
,
Save
AV
,
Xu
Y
,
Elliston
CD
,
Garrett
MD
,
Wu
CC
, et al.
Frameless stereotactic radiosurgery on the gamma knife icon: early experience from 100 patients
.
Neurosurgery
.
2020
;
86
(
4
):
509
16
. .
12.
Dincoglan
F
,
Beyzadeoglu
M
,
Sager
O
,
Oysul
K
,
Sirin
S
,
Surenkok
S
, et al.
Image-guided positioning in intracranial non-invasive stereotactic radiosurgery for the treatment of brain metastasis
.
Tumori
.
2012
;
98
(
5
):
630
5
. .
13.
Ramakrishna
N
,
Rosca
F
,
Friesen
S
,
Tezcanli
E
,
Zygmanszki
P
,
Hacker
F
.
A clinical comparison of patient setup and intra-fraction motion using frame-based radiosurgery versus a frameless image-guided radiosurgery system for intracranial lesions
.
Radiother Oncol
.
2010
;
95
(
1
):
109
15
. .
14.
St George
EJ
,
Kudhail
J
,
Perks
J
,
Plowman
PN
.
Acute symptoms after gamma knife radiosurgery
.
J Neurosurg
.
2002
;
97
(
5 Suppl
):
631
4
. .
15.
Bichay
TJ
,
Mayville
A
.
The continuous assessment of cranial motion in thermoplastic masks during cyberKnife radiosurgery for trigeminal neuralgia
.
Cureus
.
2016
;
8
(
5
):
e607
. .
16.
Sayer
FT
,
Sherman
JH
,
Yen
CP
,
Schlesinger
DJ
,
Kersh
R
,
Sheehan
JP
.
Initial experience with the eXtend system: a relocatable frame system for multiple-session gamma knife radiosurgery
.
World Neurosurg
.
2011
;
75
(
5–6
):
665
72
. .
17.
McTyre
E
,
Helis
CA
,
Farris
M
,
Wilkins
L
,
Sloan
D
,
Hinson
WH
, et al.
Emerging indications for fractionated gamma knife radiosurgery
.
Neurosurgery
.
2017
;
80
(
2
):
210
6
. .
18.
Arino
C
,
Stadelmaier
N
,
Dupin
C
,
Kantor
G
,
Henriques de Figueiredo
B
.
[Thermoplastic mask in radiotherapy: a source of anxiety for the patient?]
.
Cancer Radiother
.
2014
;
18
(
8
):
753
6
. .
19.
Clifford
W
,
Sharpe
H
,
Khu
KJ
,
Cusimano
M
,
Knifed
E
,
Bernstein
M
.
Gamma knife patients’ experience: lessons learned from a qualitative study
.
J Neurooncol
.
2009
;
92
(
3
):
387
92
. .
20.
Williams
JR
,
Venchiarutti
RL
,
Smee
R
.
A prospective patient-focused evaluation of the tolerance and acceptability of a stereotactic radiosurgery procedure
.
J Clin Neurosci
.
2017
;
40
:
91
6
. .
21.
Cao
H
,
Xiao
Z
,
Zhang
Y
,
Kwong
T
,
Danish
SF
,
Weiner
J
, et al.
Dosimetric comparisons of different hypofractionated stereotactic radiotherapy techniques in treating intracranial tumors >3 cm in longest diameter
.
J Neurosurg
.
2019
;
1
9
. .
22.
Kondziolka
D
,
LoPresti
M
,
Tyburczy
A
,
Golden
C
,
Seto
T
,
Boulio
L
, et al.
Quality of the patient experience during radiosurgery: measurement toward improvement
.
Stereotact Funct Neurosurg
.
2016
;
94
(
3
):
134
9
. .
23.
Menkes
DB
,
Davison
MP
,
Costello
SA
,
Jaye
C
.
Stereotactic radiosurgery: the patient’s experience
.
Soc Sci Med
.
2005
;
60
(
11
):
2561
73
. .
24.
Cerviño
LI
,
Pawlicki
T
,
Lawson
JD
,
Jiang
SB
.
Frame-less and mask-less cranial stereotactic radiosurgery: a feasibility study
.
Phys Med Biol
.
2010
;
55
(
7
):
1863
73
. .
25.
Singh
JA
,
Sloan
JA
,
Atherton
PJ
,
Smith
T
,
Hack
TF
,
Huschka
MM
, et al.
Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the control preferences scale
.
Am J Manag Care
.
2010
;
16
(
9
):
688
96
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.